JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
INBX - Inhibrx Biosciences, Inc.
USD | NASDAQ | Healthcare
Summary
Summary INBX Stock
Financials
Financials INBX Stock
Loading...
Loading...
Income Statement
Income Statement INBX Stock
Balance Sheet
Balance Sheet INBX Stock
Cash Flow Statement
Cash Flow Statement INBX Stock
Loading...
Loading...
Home
Stocks
Inhibrx Biosciences, Inc. (INBX)
Financials
Financials of INBX
Loading...
Loading...
Loading...
Loading...
INBX Financials - Inhibrx Biosciences Income & Cash Flow | Ledgeburg
Revenue
$1.3M
Operating Income
$-135.025M
Net Income
$-140.055M
Share Count (Basic)
15.487M
Operating Cash Flow
$-129.794M
Free Cash Flow
$-129.825M
Cash And Short-Term Equivalents
$124.22M
Total Debt
$100.559M
Annual
Quarterly
Revenue $USD
0
500K
1M
1.5M
FY2023
FY2024
FY2025
Revenue $USD
0
500K
1M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
0
500M
1B
1.5B
FY2023
FY2024
Annual
Quarterly
Margins
Gross
Operating
Net
-200000%
0%
200000%
400000%
600000%
800000%
FY2025
Net Income $USD
-40M
-35M
-30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2200%
-2180%
-2160%
-2140%
-2120%
-2100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26